Last reviewed · How we verify

live attenuated JE vaccine

Changchun Keygen Biological Products Co., Ltd. · FDA-approved active Biologic Quality 5/100

live attenuated JE vaccine is a Biologic drug developed by Changchun Keygen Biological Products Co., Ltd.. It is currently FDA-approved.

At a glance

Generic namelive attenuated JE vaccine
SponsorChangchun Keygen Biological Products Co., Ltd.
ModalityBiologic
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about live attenuated JE vaccine

What is live attenuated JE vaccine?

live attenuated JE vaccine is a Biologic drug developed by Changchun Keygen Biological Products Co., Ltd..

Who makes live attenuated JE vaccine?

live attenuated JE vaccine is developed and marketed by Changchun Keygen Biological Products Co., Ltd. (see full Changchun Keygen Biological Products Co., Ltd. pipeline at /company/changchun-keygen-biological-products-co-ltd).

What development phase is live attenuated JE vaccine in?

live attenuated JE vaccine is FDA-approved (marketed).

Related